933775-38-3

Upstream product

• 933775-47-4 3-benzyl-6-methyl-[1,2,3]oxathiazinane 2-oxide 
• 933775-35-0 2-(3-benzylamino-1-methyl-propyl)-malonic acid diethyl ester 
• 146679-28-9 (R)-4-benzylamino-2-butanol 
• 146679-25-6 (R)-N-benzyl-3-hydroxybutyramide 
• 100-46-9 benzylamine 
• 933775-26-9 (R)-3-benzyl-6-methyl-[1,2,3]-oxathiazinane-2,2-dioxide 
• 933775-37-2 (S)-2-[3-(benzyl-tert-butoxycarbonylamino)-1-methylpropyl]-malonic acid diethyl ester 

Downstream Products

• 933775-39-4 2-[3-(benzyl-tert-butoxycarbonyl-amino)-1-methyl-propyl]-2-(3-oxo-butyrylamino)-malonic acid diethyl ester 
• 933775-42-9 (7S,7aR)-3-acetyl-4-benzyl-7-methyl-1,4,5,6,7,7a-hexahydropyrrolo(3,2-b)-pyridin-2-one 
• 933775-49-6 3-acetyl-5-(3-benzylamino-1-methyl-propyl)-pyrrolidine-2,4-dione 
• 933775-41-8 [3-(4-acetyl-3,5-dioxo-pyrrolidin-2-yl)-butyl]-benzyl-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Stereospecific construction of substituted piperidines. Synthesis of (-)-paroxetine and (+)-laccarin

Short and efficient enantioselective syntheses of (-)-paroxetine and (+)-laccarin are described based on the highly stereospecific cleavage of C(3)-substituted 1,3-cyclic sulfamidates. The Royal Society of Chemistry.